Koyfin Home > Directory > Health Care > Amicus Therapeutics > Total Debt / Equity

Amicus Therapeutics Total Debt / Equity Chart (FOLD)

Amicus Therapeutics annual/quarterly Total Debt / Equity from 2006 to 2018. Debt to equity is a measure of leverage in a company and expressed as a ratio of the total debt relative to book value of equity.
  • Amicus Therapeutics Total Debt / Equity for the quarter ending September 09, 2018 was $78m a 39.91% increase of 31m year over year
  • Amicus Therapeutics Total Debt / Equity for the last 12 months ending September 09, 2018 was $78m a 39.91% increase of 31m year over year
  • Amicus Therapeutics Annual Total Debt / Equity for 2017 was $47m a 7.65% increase of 4m from 2016
  • Amicus Therapeutics Annual Total Debt / Equity for 2016 was $43m a 72.16% increase of 31m from 2015
  • Amicus Therapeutics Annual Total Debt / Equity for 2015 was $12m a 1.80% increase of 0m from 2014
Other Ratios Metrics:
  • Amicus Therapeutics Total Debt / Capital for the quarter ending September 09, 2018 was $44m a 27.22% increase of 12m year over year
  • Amicus Therapeutics Other Liabilities for the quarter ending December 12, 2018 was $39m a -4.44% decrease of -2m year over year
View Chart On Koyfin

Quarterly FOLD Total Debt / Equity Data

09/2018$78m
06/2018$30m
03/2018$32m
12/2017$47m
09/2017$39m
06/2017$60m
03/2017$50m
12/2016$43m
09/2016$20m
06/2016$20m

Annual FOLD Total Debt / Equity Data

2017$47m
2016$43m
2015$12m
2014$12m
2013$32m
2012$1m
2011$4m
2010$4m
2009$5m
2008$2m